At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 94 enrolled
Drug / intervention
Cantharidin +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized Pilot Study Investigating the Safety and Efficacy of Topical Cantharidin for the Treatment of Molluscum Contagiosum
In Brief
A Phase 2 clinical trial evaluating Cantharidin, Placebo, and 1 other intervention for Molluscum Contagiosum. Completed, enrolled 94 participants.
Detailed Summary
The purpose of this study is to determine if cantharidin is a safe and effective treatment for molluscum contagiosum in kids
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMolluscum Contagiosum
Countries--
Collaborators--
Timeline
Phase 2CompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartJul 2012
Primary CompletionNov 2015
Study CompletionJan 2016
First PostedJan 2016
TodayJul 2026
First PostedJan 27, 2016
Enrollment StartJul 1, 2012
Primary CompletionNov 1, 2015
Study CompletionJan 1, 2016
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 10.4 years ago
Interventions
Cantharidindrug
cantharidin 0.7% topical liquid
Placebodrug
Placebo topical liquid
Gauze occlusion bandagedevice
Gauze occlusion bandage with adhesive tape